首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

European Journal Of Clinical Pharmacology

European Journal Of Clinical Pharmacology杂志,由Springer Berlin Heidelberg出版,于1968年创刊,Monthly,出版语言English,ISSN:0031-6970,E-ISSN:1432-1041。

投稿咨询
European Journal Of Clinical Pharmacology
European Journal Of Clinical Pharmacology
European Journal Of Clinical Pharmacology
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.5
CiteScore
5.6
期刊收录
SCI、SCIE

European Journal Of Clinical Pharmacology(中文译名:《欧洲临床药理学杂志》),ISSN:0031-6970,EISSN:1432-1041,是Springer Berlin Heidelberg出版的国际性学术期刊,创刊于1968年,以Monthly形式稳定发行,2026年总发文量约126篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.5,2025年期刊CiteScore为5.6,2025年期刊自引率约2.9%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。European Journal Of Clinical Pharmacology长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期一般,3-8周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,FranceSpain、CHINA MAINLAND、Netherlands、GERMANY (FED REP GER)、USA、Sweden等为核心发文国家与地区;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)KAROLINSKA INSTITUTET、UNIVERSITY OF AMSTERDAM、ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP)、CHU DE TOULOUSE、VRIJE UNIVERSITEIT AMSTERDAM、AUTONOMOUS UNIVERSITY OF BARCELONA等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 134 / 356

62.5

学科:PHARMACOLOGY & PHARMACY SCIE Q2 161 / 356

54.92

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 164 / 352

53.6

学科:PHARMACOLOGY & PHARMACY SCIE Q3 202 / 353

42.92


中国学者近期发文

1
A systematic review and meta-analysis of exposure-response analysis of osimertinib in patients with non-small-cell lung cance

Author:Shao, Weifeng; Yang, Jingyi; Wu, Liying; Zhou, Yue; Yu, Zhiheng; Cheng, Yinchu; Cai, Qiushi; Liu, Wei

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. 82, Issue 4, pp. -. DOI: 10.1007/s00228-026-04013-x

2
Systematic review and first meta-analysis of the efficacy and safety of gemcitabine-cisplatin combined with paclitaxel in patients with advanced biliary tract cance

Author:Zhu, Gang; Li, Shenglan; Zhang, Yan; Feng, Guoying; Zhang, Guangnian; Cheng, Huanli; Jiang, Bo; Gao, Benjian; Yang, Xiaoli; Li, Bo

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. 82, Issue 4, pp. -. DOI: 10.1007/s00228-026-04031-9

3
Authors' reply to Outcomes for metastatic triple-negative breast cancer patients treated with sacituzumab govitecan in clinical studies and real-world studies: a single-arm meta-analysi

Author:Liang, Shuang; Liao, Weiwei; Jiang, Junhao; Bao, Yujian; Zheng, Hang

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. 82, Issue 4, pp. -. DOI: 10.1007/s00228-026-04038-2

4
Population pharmacokinetic modeling and Monte Carlo simulation-based dosing optimization of trimethoprim-sulfamethoxazole in critically ill patient

Author:Wang, Min; Li, Chen; Fu, Xiangxiang; Wang, Fangling; Zhou, Xiaojun; Zhang, Bingli; Xu, Wenya; Liang, Liqiu; Lei, Zhenlin; Qu, Hengxing; Xie, Ling; Zhong, Lili; Zheng, Yuanyuan; Liu, Tao

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. 82, Issue 4, pp. -. DOI: 10.1007/s00228-026-04019-5

5
Innovative applications of artificial intelligence technology in pharmacometric

Author:Luo, Jieren; Yu, Jiesen; Cai, Zihao; Xu, Ling; Lv, Yinghua; Zheng, Qingshan; Li, Lujin

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. 82, Issue 4, pp. -. DOI: 10.1007/s00228-026-04032-8

6
Population pharmacokinetics of rivaroxaban after transjugular intrahepatic portosystemic shun

Author:Jia, Min; Chai, Yiming; Gao, Yuan; Jing, Changyou; Zhu, Kunlei; Zhu, Tong; Wang, Liang; Sun, Aili; Yang, Jun; Zhu, Yanqiu; Feng, Yingmei; Cao, Yu; Li, Jianjun

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. 82, Issue 4, pp. -. DOI: 10.1007/s00228-026-04034-6

7
To the Editor: Levosimendan in sepsis-induced cardiac dysfunction: consolidating evidence within a complex clinical landscap

Author:Shaibu, Zakari; Zhu, Wei

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. 82, Issue 4, pp. -. DOI: 10.1007/s00228-026-04036-4

8
Economic evaluation of sodium-glucose transporter 2 inhibitors compared with glucagon-like peptide 1 receptor agonist for the treatment of type 2 diabetes: a systematic revie

Author:Wang, Lu; Wang, Yinglin; Zhao, Quan

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. 82, Issue 4, pp. -. DOI: 10.1007/s00228-026-04015-9

9
Trough concentration of voriconazole and its association with central nervous system toxicity in patients with hematologic malignancies: a retrospective cohort stud

Author:Zhang, Qinghua; Chen, Junwei; Tan, Wenming; Li, Weien; Tan, Lirong; Wen, Xiuling

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. 82, Issue 4, pp. -. DOI: 10.1007/s00228-026-04024-8

10
Exploring potential biomarkers and constructing prediction models of osimertinib based on a retrospective stud

Author:Cui, Lili; Tang, Mao; Liang, Suli; Bu, Chen; Yun, Yunlei; Gao, Shouhong; Wang, Zhipeng; Tao, Xia

Journal: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. 82, Issue 3, pp. -. DOI: 10.1007/s00228-025-03940-5


在线咨询

European Journal Of Clinical Pharmacology

国际简称:EUR J CLIN PHARMACOL参考译名:欧洲临床药理学杂志

年发文量:126 CiteScore:5.6 是否预警:否 Gold OA文章占比:29.41% 研究类文章占比:69.84%

杂志社联系方式:SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

European Journal Of Clinical Pharmacology